Heart Attack Care: Drugs vs. Stents
Analysis Shows Drugs After Heart Attack Are Effective and Reduce Costs
Feb. 18, 2009 -- Opening blocked arteries with balloon angioplasty and
stents can save lives during a heart attack, but the invasive treatment offers
little added value over heart drugs alone in patients first treated days and
even weeks later.
Now a new analysis shows that avoiding stenting in stable late-presenting
patients could result in a yearly savings of around $700 million in health care
"What we have here is one of those cases where less is more," says
researcher Daniel B. Mark, MD, MPH, of Duke University Medical Center.
Stents Most Useful Early
Clearing blocked arteries in the early stages of a heart attack can restore
blood flow before heart muscle is permanently damaged.
But as many as a third of the roughly 1 million Americans who have heart
attacks each year are treated more than 12 hours after their first symptoms
appear, when heart damage is likely to have already occurred, Mark tells
Clot-busting drugs are not an option when treatment is delayed, but bare
metal or drug-coated metal stents were often implanted to prop open and clear
blocked arteries in late-presenting patients, even when they had no angina
(chest pain) or other physical symptoms.
In the Occluded Artery Trial (OAT), a major, federally funded study
published two years ago, Mark and colleagues reported that late-presenting
heart attack patients with blocked arteries had no better long-term outcomes
when they were treated with balloon angioplasty and stents than when treated
with drugs alone. These results led to major changes in the management of such
patients by many cardiologists.
All of the patients enrolled in OAT were clinically stable with no chest
pain, and all received appropriate medical treatment with drugs like aspirin,
beta-blockers, ACE inhibitors, and statins.
Quality of Life and Treatment Costs
In a new report, published in the Feb. 19 issue of the New England
Journal of Medicine, Mark and colleagues further analyzed the OAT data.
They examined quality-of-life measurements and treatment costs among the two
Quality of life was determined through standardized questionnaires
administered either face-to-face or by telephone at enrollment and at 4, 12,
and 24 months.
Four months after enrollment, the stent patients did report less chest pain
and scored higher on quality-of-life assessments. But the differences were
small and they had disappeared altogether within a year, Mark says.
"We saw no discernable differences in what patients said they were able
to do or in any other major measure of quality of life and well-being," he
The average cost of hospital and physician care during the first 30 days of
treatment was calculated to be $22,859 per patient treated with balloon
angioplasty and stenting vs. $12,683 for the medical therapy group.
Over two years of treatment, medical costs among patients treated with
angioplasty and stents were an average of $7,000 higher than patients who did
not get angioplasty and stents.